関連する実験動画
Updated: Apr 3, 2026

06:06
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
6.2K
ユービキチン・リゲーゼをプロシシブからディストリビューティブの酵素メカニズムに切り替える小分子
Stefan G Kathman1, Ingrid Span1, Aaron T Smith1
1Center for Molecular Innovation and Drug Discovery, Chemistry of Life Processes Institute, Department of Chemistry, Department of Molecular Biosciences, Northwestern University , Silverman Hall, 2145 Sheridan Road, Evanston, Illinois 60208, United States.
Journal of the American Chemical Society
|September 16, 2015
まとめ
研究者らは,E3リガゼNedd4-1のプロセシビティを突然変異または小分子を使って切り替えることで,そのメカニズムが変化することを発見しました. この発見は,様々な疾患に対する標的型E3リガース阻害剤の開発の新しい戦略を示しています.
科学分野:
- 生物化学
- 分子生物学
- 酵素学
背景:
- E3リガゼは多くのヒト疾患において重要な役割を果たしますが,そのメカニズムは未だに完全に理解されていません.
- E3リガースの機能を調査する薬理学的ツールが非常に必要である.
研究 の 目的:
- HECT E3 リガゼ Nedd4-1の酵素メカニズムを調査する.
- Nedd4-1の阻害剤を発見し,特徴づけること.
- Nedd4-1の活動に対するプロセシビティの障害の影響を調査する.
主な方法:
- 酵素のプロセシビティを研究する生化学的分析
- 阻害剤の結合モードを決定するX線結晶学.
- 酵素動力学と構造生物学技術
主要な成果:
- Nedd4-1はプロセッシブ酵素として識別された.
- 変異や小分子によるNedd4-1のプロセシビティの破壊は,そのメカニズムを分散型ポリウビキチン鎖合成にシフトさせた.
- Nedd4-1の最初の共性阻害剤が発見され,構造的に特徴づけられ,配分メカニズムへのスイッチも誘導された.
- 漸進的なNedd4-1は,配分性阻害剤結合形態とは異なり,USP8の存在下でポリウビキチン鎖を合成した.
結論:
- 新しいE3阻害剤を開発するための有望な戦略です.
- この研究は,HECT E3酵素のメカニズムに関する基本的な洞察を提供します.
- Nedd4-1を標的とする新しいHECT E3阻害剤が発見されました.
関連する概念動画
The Proteasome
2.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K
The Proteasome
10.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.6K
The Proteasome
5.1K
5.1K
Regulated Protein Degradation
9.3K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.3K
Intralumenal Vesicles and Multivesicular Bodies
5.2K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
5.2K
Export of Misfolded Proteins out of the ER
5.7K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.7K

